Request Deal Involvement
Goldman Sachs to invest $150m in Biocon Biologics at a $3.9bn valuation.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Principals
target
BIOCON BIOLOGICS LTD
bidder
GOLDMAN SACHS (MERCHANT BANKING DIVISION)
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite